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Summary
Objective: To determine whether differentiated chondrocytes are motile.
Design: Calf articular chondrocytes isolated from six animals were cultured in spinner flasks and removed on days 3 and 7. Boyden chamber
assays and time-lapse videomicroscopy were performed to monitor and quantify cell migration. A novel method for selectively harvesting and
metabolically labeling the migrated cells was developed, based on cell movement to the underside of the Boyden chamber membranes. The
3H-collagen synthesized by these cells was purified and analyzed by SDS-PAGE and autoradiography either before or after cyanogen
bromide cleavage.
Results: In Boyden chambers, locomotion of day 3 chondrocytes on fibronectin-coated membranes was ∼3-fold higher than on bovine serum
albumin-coated controls (39±15 vs 12±8 cells/mm2, respectively (P0.005)). Insulin-like growth factor-I (IGF-I, 10 ng/ml) was chemotactic,
increasing motility to 87±16 cells/mm− (difference from fibronectin alone: P0.0003). A similar response was observed for day 7 cells, but
IGF-I activation was not as pronounced (P0.055). The collagen patterns produced by the migrated cells closely resembled those of
standard collagen type II, without any evidence of collagen I production. In videotracking experiments, motile cells attached on fibronectin
exhibited typical lamellipodia and filopodia, and ∼30% of attached cells were motile (speed >1 µm/h and directional persistence >1 h). Typical
cell path lengths were 30–50 µm, substantially greater than a full cell length displacement.
Conclusion: A population of well-differentiated chondrocytes capable of matrix (COL II) synthesis are motile in vitro. This original finding
opens new avenues to study the potential of motile cells for cartilage repair.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Articular cartilage performs a highly specialized mechanical
function, covering and protecting bone from weight-bearing
forces several times the weight of the body. Despite
the potential for cartilage damage from abnormal impact,
resident chondrocytes seem unable to heal tissue injury.
This problem can lead to deep macroscopic fissuring
and/or progress to osteoarthritis1,2. Cultivation and expan-
sion of isolated chondrocytes have been used as the basis
for the preparation of various types of cell composites to
seed focal cartilage defects3–6, but these have not been
consistently successful. A current focus of interest is the
development of strategies to integrate the neocartilage
formed from the implanted cells with the adjacent carti-
lage7,8. Impaired ability of chondrocytes to migrate for a
significant distance into the surrounding tissue lattices
where they can form a functional bridging matrix may
contribute to lack of durable repair.
Cell migration is a highly complex, exquisitely regulated
process whereby a vast molecular machinery of inter-
calated pieces is organized and coordinated to serve
dynamic physical ends; these include protrusion of a lamel-
lipodia that serves to attach the cell in the direction of
movement, contraction of the cell body and detachment of
the rear to allow forward motion. Indeed, directed move-
ment allows cells to participate in diverse normal and
pathological functions, ranging from tissue modeling during
embryogenesis and connective tissue repair to neoplastic
invasion and metastasis of cancer cells9,10. Most cells in
the body are able to move, but chondrocytes are con-
sidered a non-motile cell type. Despite the potential
physiological and clinical importance of this concept, the
ability of chondrocytes to migrate has not been rigorously
examined.
In a limited number of studies, migration of cells initially
obtained from cartilage has been noted11–13. While these
studies are very encouraging, they may be confounded by
the fact that chondrocytes have a well-known propensity for
losing their differentiated function following attachment in
monolayers14,15. The studies have not addressed this
question in depth, and/or the analysis has led to the
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conclusion that the migratory cells are of the fibroblastic
phenotype. Additional studies suggest that chondrocytes
possess some of the properties associated with moto-
genesis, including the formation of dynamic membrane
protrusions and contractility of the cell body. Indeed, time-
lapse high-resolution videomicroscopy has revealed that
chondrocytes may grab on to, and pull and bend collagen
fibers16. In agreement with this, it has been demonstrated
that there is a subpopulation of chondrocytes in the super-
ficial zone of human and canine cartilage that expresses α
smooth muscle actin, a temporally regulated contractile
protein expressed by myofibroblasts during dermal wound
healing17–20. In this article, we address the question of
chondrocyte motility by examining and quantifying the
ability of chondrocytes to migrate through three-
dimensional (3D) porous matrices and on 2D surfaces, and
seek direct evidence for the differentiated state of the
migratory chondrocytes.
Materials and methods
MATERIALS
Pronase was obtained from Calbiochem Corporation,
San Diego, CA; Collagenase P from Roche Molecular
Biochemicals, Indianapolis, IN; fetal calf serum (FCS) from
Hyclone Laboratories, Logan, Utah. GlutaMAX-1, Pluronic
F-68, HEPES, phosphate buffered saline (PBS), pH 7.4,
Hanks balanced salt solution (HBSS), Dulbecco’s
modified Eagle’s media (DMEM), DMEM/F12 and
penicillin/streptomycin were all from Invitrogen/GIBCO BRL
Lifetechnologies, Grand Island, NY. Crystal violet, trypan
blue, β aminopropionitrile, pepsin and cyanogen bromide
(CNBr) were from Sigma Aldrich Fine Chemicals, St. Louis,
MO. Human plasma fibronectin (FN) was from Chemicon
International, Inc., Temecula, CA, and human recombinant
(Hr) insulin-like growth factor-I (IGF-I) was from R&D
systems, Minneapolis, MN. The 3H-proline was from
Amersham Pharmacia Biotech, Piscataway, NJ. All SDS
polyacrylamide gels, sample and electrophoresis buffers
and colloidal blue were from Invitrogen Life Technologies,
Carlsbad, CA. Drs James Wu and David Eyre (University
of Washington, Seattle, Washington) generously provided
CNBr-derived peptides of bovine collagen II.
CARTILAGE HARVEST AND CELL CULTURE
Bovine articular cartilage was dissected from the meta-
carpalphalangeal joints of newborn calves (∼4–8 weeks
old), avoiding the underlying bone and/or soft tissues.
Cartilage slices were rinsed three times in Ca2+-free HBSS
and cultured in DMEM containing 3.5 g/l HEPES overnight.
Chondrocyte isolation followed the method of Kuettner
et al.21, digesting the tissue with 0.2% (w/v) pronase for 1 h,
and then with 0.025% collagenase-P for 22 h. One joint
typically yielded 60 to 80 million cells with 100% viability
(assessed by trypan blue exclusion). Chondrocytes were
suspended at 500 000 to 750 000 cells/ml in suspension
culture medium: (Ca2+-free DMEM supplemented with 1%
GlutaMAX-I, 0.1% Pluronic-F68, 0.1 U/ml penicillin,
0.1 µg/ml streptomycin and 10% FCS), transferred to a
spinner flask and maintained with gentle stirring. On days 3
and 7 of culture, aliquots of chondrocytes were removed
from the spinner flask for migration assays. Cells were
rinsed by centrifugation in Ca2+ and serum-free DMEM,
and resuspended at the appropriate concentration in
DMEM/F12 containing 3.5 g/l HEPES, 0.1 U/ml penicillin
and 0.1 µg/ml streptomycin (cell migration assay medium).
BOYDEN CHAMBER CHEMOTAXIS ASSAY
Routine assays were performed using 24-well cell culture
inserts with polyethylene terephthalate membranes with
8 µm pores (Becton Dickinson). The inserts were prepared
prior to assay by incubating both sides of the membrane
for 2 h at room temperature (RT) with human plasma FN (for
routine assays: 3 µg/ml FN). The FN solution was aspirated
off, and the membranes were incubated in 0.1% (w/v) bovine
serum albumin (BSA) for 1 h at RT to block unspecific
binding sites, rinsed three times with PBS and stored at 4°C
overnight. Cells (2×105/0.3 ml) were allowed to attach to the
top wells of the inserts for 48 h under serum and growth
factor-free conditions. (This maintained the upper chamber
free of growth factors that could interfere with the steepness
and effectiveness of the chemotactic gradient in the sub-
sequent migratory phase. The alternative of using serum
could leave residual growth factors attached to newly syn-
thesized matrix or cell surfaces and require a further serum
starvation phase. For these experiments, the priority was
maintaining the period of monolayer culture short to mini-
mize the chances of phenotype loss). Immediately following
the adhesion phase, growth factors in 0.1% BSA were
added to the lower wells as indicated, or alternatively, 0.1%
BSA was added alone to control wells. After 24 h, non-
migrated cells on the top surface of the inserts were re-
moved with a cotton-tipped swab, and the cells remaining on
the inserts were then stained with 0.1% crystal violet (w/v) in
0.1 M borate, pH 9.0 (Sigma) and 2% ethanol for 30 min at
RT22. The number of migrated cells on the underside of the
membrane was counted within a 1 mm2 field under a light
microscope at 200× magnification; six fields were counted
for each membrane and the number of cells averaged. For
the experiments shown in Fig. 2, the same six relative
positions were counted for all inserts by using a marked grid.
The student’s two-tailed t-test assuming unequal variances
was used to calculate P values.
HARVESTING OF MIGRATED CELLS AND COLLAGEN PHENOTYPE
ASSAYS
Boyden chamber inserts for six-well plates were coated
in identical manner as the 24-well inserts, and the cell
attachment and migration procedures were performed as
described previously, except that conditions were adapted
for the larger inserts (e.g., 2.8 million cells/1.5 ml). Follow-
ing the 24-h migration period and the removal of non-
migrated cells from the top of the membranes, a scalpel
was used to cut a 1.7 cm×1.7 cm section out of each
chamber. Six cut-outs, one from each insert, were trans-
ferred to a petri dish containing 4 ml of DMEM/F12 medium
supplemented with 10 ng/ml IGF-I, 0.1% BSA, 80 µCi/ml
3H-proline, 50 µg/ml ascorbic acid and 50 µg/ml
β-aminopropionitrile. After 24 h at 37°C, medium was
reserved and cells extracted in 15 mM Tris–HCl, 0.3 M
NaCl, 0.2 M glycine and 0.1% Triton-X by gently shaking
the membranes for 20 min at 4°C. The media and resulting
extracts were combined, and 3 mM N-ethylmaleimide and
5 mM ethyl diamine tetra acetic acid (EDTA) were added.
After concentrating the extracts ∼2–2.5-fold on a
centriplus YM-3 filter (Millipore Corporation, Bedford, MA),
samples were adjusted to 0.5 M acetic acid and treated
with 100 µg/ml pepsin (Sigma) for 5 h at 4°C. Samples
were adjusted to 3 M NaCl by addition of solid salt and
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gently shaken overnight (4°C). Following centrifugation
(14 000 rpm, 30 min, 4°C), the pellet was resuspended in
0.05 M NH4HCO3, pH 8.1 and dialyzed against 1000 vol-
umes of the same buffer, with three changes of solution
(4°C). After determination of the protein and 3H-activity of
the dialyzed collagen preparation, appropriate aliquots
were dried by speed vacuum centrifugation. Homogeneity
of the purified 3H-collagens was verified by electrophoresis
on 4–12% Bis-Tris gels and staining with colloidal blue.
Type analysis of purified chondrocyte collagens was
routinely done by addition of 8300 cpm of 3H-labeled
protein per lane to 6% Tris-glycine gels and performing
SDS-PAGE as recommended by InVitrogen. Following
electrophoresis, gels were fixed, immersed in EnHance
(NEN, Boston, MA), dried and exposed to Hyperfilm MP
(Amersham Pharmacia) with a Biomax transcreen LE
(Eastman Kodak Co., Rochester, NY) at −70°C for 1 week.
PREPARATION OF CNBR PEPTIDES
The 3H-labeled collagens (prepared as described pre-
viously) or standards were subjected to CNBr cleavage
following methods similar to those described by Miller
et al.23 by adding CNBr in 70% formic acid to purified
collagens (molar ratio of 140:1 CNBr:methionine residues),
flushing the reaction vial with nitrogen prior to sealing and
then incubating for 24 h at RT. The peptides were sep-
arated on 12% NuPage Bis-Tris gels (Invitrogen) and the
dried gels subjected to autoradiography by exposure to
Kodak Biomax MS film with transcreen LE for 3 weeks.
TIME-LAPSE VIDEOMICROSCOPY
Delta T Culture Dishes (Bioptechs Biological Optical
Technologies, Butler, PA) with 35-mm diameter (23-mm
central aperture) were coated with 3 µg/ml FN, as
described for the Boyden chamber membranes. Chondro-
cytes (42 000 cells/1.75 ml) were allowed to attach under
serum-free conditions for 48 h and then IGF-I (10 ng/ml)
was added 6 h prior to videotracking. The sealed dish was
placed on a motorized stage maintained at 37°C by a
temperature controller (Bioptechs) for a Zeiss Axiovert 35
inverted phase contrast microscope. Single cells attached
to the substratum in approximately 20 different fields of the
dish were identified and captured every 15 min for 12 h by
a Nikon camera and a Hamamatsu camera controller.
Digital images were collected and saved with image
processing software Openlab (Improvision, Coventry,
England) running on a Power Macintosh computer. Images
for each field were converted to QuickTime movie format,
and each cell’s centroid position was recorded over the
12 h period using DIAS (Solltech, Inc., Oakdale, Iowa).
Centroid data were then transferred to a spreadsheet
program (Microsoft Excel, Redmond, Washington, DC) for
further manipulation.
Cell migration parameters were calculated from the
experimental data as described before24. Briefly, using
spatial coordinates of the cell centroid for each time interval
obtained from image processing, mean-squared displace-
ments from {x(t), y(t)} to {x(t+i∆t), y(t+i∆t)} for each time
point n∆t were calculated as (Eq. (1))
d2(t=n∆t) 1(N−n+1) i=0
N−n
[x((n+i)∆t)−x(i∆t)]2
[y((n+i)∆t)−y(i∆t)]2 (1)
Centroid positions were converted from pixels to microns
using the conversion of 0.685 µm/pixel. Experimental
mean-squared displacement calculations were performed
using Matlab (The Mathworks, Inc., Natick, MA). The
parameters for speed (S) and persistence (P) were
obtained by fitting Eq. (2)
d2=2S2P[t−P(1−e−t/P)] (2)
to experimental data from Eq. (1) by the Levenberg–
Marquardt method for non-linear least squares regression
using DataFit (Oakdale Engineering, Oakdale, PA)24.
Results
DETERMINATION OF CONDITIONS TO PROMOTE MIGRATION OF
STABLE CHONDROCYTES
In agreement with previous studies15,25,26, chondrocytes
maintained their differentiated status and synthesis of col-
lagen type II in spinner culture (data not shown). An
objective of the first experiment was to determine if FN
could support chondrocyte attachment and migration. This
matrix substratum promotes migration of several cell types
and is an important cartilage component. In addition, the
ability of IGF-I to induce chemotaxis of chondrocytes was
tested, since: (1) IGFs promote migration of other cells27
and (2) importantly, the IGFs promote or maintain the
differentiated expression of chondrocytes28,29. Figure 1
shows that under basal conditions (no added growth
factors), chondrocytes increased their migration on Boyden
chambers coated with 1 µg/ml FN compared with chambers
coated only with BSA. Migration was maintained at a
Fig. 1. Effect of FN substrata and IGF activation on chondrocyte
migration. Boyden chamber membranes were coated with the
indicated concentration of FN (section Materials and Methods).
Chondrocytes derived from day 3 spinner cultures were allowed to
attach under serum- and growth factor-free conditions. Where
indicated, IGF-I at 10 ng/ml was added to the lower chamber of
Boyden chambers after a 48 h attachment period. After an ad-
ditional 24 h, the cells on the upper chamber were removed and
cells on the underside of the Boyden membranes were counted in
six random fields/chamber. The average of duplicate chambers is
shown, except for the data points at 3 µg/ml FN and 3 µg/ml
FN+10 ng/ml IGF-I, which are the averages from three exper-
iments with separate batches of chondrocytes. The bars are the
standard deviations and the numbers refer to the number of
replicate Boyden chambers analyzed.
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relatively constant level over a 10-fold concentration of
FN. Addition of IGF-I at a saturating concentration of
10 ng/ml to the lower wells of the Boyden chambers
further enhanced migration on and through FN-coated
membranes.
CHONDROCYTE MIGRATION: TIME IN CULTURE
A series of six experiments with chondrocytes obtained
from articular cartilage of different calves was then con-
ducted to validate the reproducibility and define the stat-
istical significance of the observations. Aliquots from the
same chondrocyte stocks were analyzed in parallel by
Boyden chamber assay and by videotracking microscopy,
and the phenotypic expression of migrated cells was deter-
mined in selected samples. Figure 2 shows that when
chondrocytes are harvested on day 3 of spinner culture
and allowed to attach on Boyden chamber membranes, the
FN substratum significantly increases chondrocyte migra-
tion over that seen on BSA-coated membranes by an
average of 3.3-fold (N6 experiments; Student’s t-test,
P0.005). Addition of IGF-I at 10 ng/ml to the lower
chambers of FN-coated vessels further enhanced chondro-
cyte motility by an average of 2.2-fold compared with the
untreated samples (N6; P0.0003). In four of the exper-
iments, the assays were repeated on cells harvested from
suspension culture on day 7, and FN and IGF-I also
stimulated migration. While the stimulation of migration by
the FN substratum was significant (P0.007) at this time
point, the enhancement by IGF-I did not reach statistical
significance (P0.055), probably due to a higher average
migration in the samples plated on FN. The reasons
underlying these observations are unknown, but possibly
the longer time period that the cells were maintained with
serum in suspension culture (7 vs 3 days) contributed to an
increase in integrin receptors and/or other critical proteins
and facilitated adhesion. If indeed the cells harvested on
the day 3 of spinner culture were not optimally activated,
they may have responded more fully to IGF-I in the Boyden
chambers as noted herein. Also consistent with this
notion, the maximal migration in the presence of the FN
substratum and IGF-I was equal on days 3 and 7.
VALIDATION OF METHOD TO SELECTIVELY ASSAY MIGRATED
CHONDROCYTES
Our next objective was to provide direct evidence of the
differentiated state of migratory chondrocytes. Collagen II is
selectively produced by chondrocytes, while collagen type I
is a ubiquitous collagen that is not produced by differ-
entiated chondrocytes. Initial experiments showed that the
cells harvested from spinner cultures and allowed to attach
on FN synthesized collagen type II, but did not produce
detectable collagen type I (data not shown). However, a
small population of fibroblastic cells, undetected by this
method, could be responsible for the migration of cells to
the underside of the Boyden chamber membranes. To
address and resolve this issue, a method for harvesting
and analyzing only the migratory population of cells was
devised and validated. Figure 3 illustrates the procedure,
which is also described in detail in the Materials and
Methods section. To determine if the technique success-
fully removes the non-migrated cells from the chambers
prior to metabolic labeling, we set up the following control
experiment. Identical chondrocyte samples were added to
the top of Boyden chambers with either the usual 8 µm pore
(cell-permeable) or 0.4 µm pore membranes (cell-
impermeable). After otherwise identical ‘migration’ condi-
tions (FN coat, no added growth factor) and removal of
non-migrated cells, the membranes were similarly excised
and incubated with 3H-proline (IGF-I was added during the
radiolabeling period to stimulate protein synthesis of any
cells on the membranes). There was a marked increase in
the cellular activity (3H-protein synthesis) associated with
the 8 vs the 0.4 µm membrane (Fig. 3, inset), supporting
the presence of migrated cells on the former membrane,
and only low levels of contaminating cells on the latter.
When the experiments with the 8 µm membrane were
conducted with IGF-I added to the lower wells of the
chambers, a further increment in the anabolic activity
associated with the excised membranes was seen (Fig. 3,
inset) due to IGF chemotaxis. The experiments place a limit
for contamination of the membranes by non-migrated cells
of <20% (compare the 3H-activity associated with 8 µm
membranes following migration in the presence of IGF-I
(i.e., the optimal migration observed in this study) to the
activity associated with 0.4 µm membranes (blocked
migration) (Fig. 3, inset).
DETERMINATION OF THE COLLAGEN TYPE PRODUCED BY
MIGRATED CHONDROCYTES
The experiments described previously indicated that the
method for harvesting migratory cells was appropriate for
Fig. 2. Chondrocyte migration in Boyden chambers; time in culture.
Chondrocytes derived from the days 3 and 7 of spinner cultures
were plated on the upper inserts of the Boyden chambers. After
48 h under serum-free conditions, IGF (10 ng/ml) was added to the
medium in the lower well of appropriate samples and all samples
were incubated for an additional 24 h. The cells that had migrated
to the underside of the Boyden membrane were counted in six
fields at identical position for each replicate in all the experiments
using the same marked grids (section Materials and Methods). For
each experiment, duplicates of each condition were run and results
averaged. Six independent experiments (chondrocytes from differ-
ent bovines) were harvested and run for day 3 cells, and in four of
these experiments, cells were also harvested and analyzed on day
7. The bars represent the average of the independent experiments
and the standard deviations are shown. P values contrast migra-
tion on FN-coated vs BSA-coated inserts, and on FN-coated,
IGF-activated chambers vs FN-coated controls without growth
factor (section Materials and Methods).
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carrying out phenotype assays. Thus, the migrated cells
were labeled with 3H-proline, the proteins extracted and the
labeled collagens enriched by pepsin digestion (which
leaves the triple collagen helix intact, but removes other
proteins). At least 40% of the 3H-labeled protein was triple
helical collagen, as defined by its macromolecular size
(pelleting by TCA) following pepsin digestion. The colla-
gens were purified by salt precipitation and then analyzed
by SDS-PAGE and autoradiography. Figure 4 shows the
presence of α1 collagen chains, but α2 chains were not
detectable. This is consistent with the expression of colla-
gen II (contains α1 (II) chains, but not the faster migrating
α2 chains) and lack of expression of collagen I (contains
both α1 (I) and α2 (I) chains). To confirm these observa-
tions, the labeled, purified collagen prepared from the
migratory cell population was subjected to CNBr cleavage
at methionine residues, and the resulting peptides were
analyzed by SDS-PAGE and autoradiography. Figure 5
shows the CNBr peptide pattern of the 3H-labeled collagen
harvested from the migrated chondrocytes contrasted
with the peptide patterns obtained from collagen I and II
standards. It is to be noted that the 3H-collagen peptides
show a very similar pattern to that of the standard collagen
II peptides (α1 (II) CB10, CB11, CB8 and CB9, 7, 12); it is
particularly noteworthy that there are minimal to undetect-
able amounts of the collagen I peptides α1 (I) CB6 and
CB3 in the migrated chondrocyte samples15,30. These
experiments strongly support the notion that the majority
of the chondrocytes in the motile population retain their
phenotype.
VIDEOTRACKING OF MOTILE CHONDROCYTES
Videotracking experiments were conducted in order to
directly observe and record chondrocyte motion. As for
previous experiments, dishes were coated with FN and
cells allowed to migrate in the presence of 10 ng/ml IGF-I.
Figure 6 shows one example each of the two extreme
behaviors that were observed in this series of experiments.
Panel A shows an example of a non-migratory cell with a
relatively contracted body and only a few, very small
membrane protrusions. Panel B shows a migratory cell,
with a flattened body and dynamic membrane extensions,
including a distinct leading edge (lamellipodia) in the direc-
tion of migration (arrows). The insets in the lower right of
Fig. 6, Panels A and B depict the overall trajectory of the
cell centroid over 720 min and clearly show lack of move-
ment for the cell in panel A, but distinct movement away
from the starting point for the cell in panel B.
Quantitative parameters of speed (S) and directional
persistence (P) describing chondrocyte motility were
derived for a large number of individually videotracked cells
in three experiments with different chondrocyte batches.
The speed can be interpreted as simply the ‘rate’ at which
a cell moves, and the persistence represents a measure of
the average time period between ‘significant’ (60°) changes
in the direction of movement24. The cells that moved at
>1 µm/h and/or had a directional persistence >1 h were
considered motile, and the fraction of the cell population
that fit these limits was calculated (section Materials and
Methods). It can be seen that ∼25–35% of the cell popula-
tion was motile when either the speed or directional per-
sistence was used as the defining criteria for cells
harvested on day 3 or 7 (Fig. 7). Because of the similarity of
cell behavior at the different times, the results were added
and the averages are shown in the top set of bars (Fig. 7).
When the speed of the combined population of motile cells
was further dissected to examine the kinetics of movement
of individual cells, it was found that approximately half of
the cells moved at >5 µm/h; of these, occasional cells were
observed moving at 50–90 µm/h (data not shown). Approxi-
mately, two-third of the motile cells exhibited directional
Fig. 3. Development of method for harvesting migrated cells. The diagram on the left side of the figure shows the technique used to harvest
the membranes with attached, migrated chondrocytes. The figure inset on the right side shows the results of the experiment carried out to
validate the technique. Briefly, chondrocytes were allowed to attach and migrate on 8 µm pore membranes or maintained under parallel
mock-migration conditions on membranes with 0.4 µm pores. All membranes were coated with FN. Following the ‘migration’ period, the cells
on the upper membrane were cleaned off, and the membranes with any attached cells were labeled with 3H-proline (section Materials and
Methods). After the labeling period, the proteins were extracted from the cell layer, and the extracts and conditioned media combined.
Incorporation of 3H-proline was assessed by 2× precipitation of proteins with 10% TCA in the presence of 0.25 mg/ml BSA in the cold.
−IGF-1, the growth factor was first added during the labeling period; +IGF-1, the growth factor was present during the migration and labeling
periods.
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persistence of 1–10 h, the remaining one-third showed
persistence >10 h. The path length of migration is propor-
tional to the product of the speed (S) and the directional
persistence (P). Path lengths were found to mainly fall in
the range 30–50 µm (data not shown).
Discussion
The inability of chondrocytes to reach and populate, in
significant numbers, a wounded site in cartilage has been
known for a long time, contributing to the consequent
assumption that chondrocytes cannot actively locomote.
Reliable analysis of chondrocyte motility may be compli-
cated by the propensity of these cells to dedifferentiate
following attachment and spreading onto surfaces—a pre-
requisite for migration studies. Nevertheless, these are
tractable problems, motivating our work here, which pro-
vides what to our knowledge is the first definitive evidence
that differentiated chondrocytes are motile.
Individual-cell videotracking experiments demonstrated
that chondrocytes express dynamic membrane changes
Fig. 4. SDS-PAGE of purified 3H-collagen produced by migrated
chondrocytes. Migrated chondrocytes were harvested and labeled
with 3H-proline as shown in Fig. 3 and detailed in Materials and
Methods section. Following purification of 3H-collagens, electro-
phoresis was run in 6% Tris-glycine gels. Lanes 1 and 2 show
duplicate samples of 3H-collagens, each lane loaded with 5900
and 8300 cpm of 3H-activity, respectively. The 3H-collagens shown
in lane 3 were derived from chondrocytes maintained in spinner
cultures for 3 weeks prior to harvesting, and then maintained
attached on FN (50 µg/ml coating concentration) in the presence of
10% FCS for 9 days to promote dedifferentiation and demonstrate
the electrophoretic separation of collagen I α2 chains. The num-
bers on the left of the figure represent the position of 14C-labeled
molecular weight standards (kDa). The 45 kDa standard coincided
with the dye front.
Fig. 5. SDS-PAGE of CNBr peptides derived from purified 3H-
collagen. Migrated chondrocytes on the underside of Boyden
chamber membranes were harvested, labeled with 3H-proline, and
the collagens extracted and purified as described in Materials
and Methods section. The purified collagens were subjected to
CNBr cleavage and SDS-PAGE using 12% NuPAGE Bis-Tris gels
and subjected to autoradiography. Lane 1 shows the collagen I
standard, lane 2 the 3H-labeled migrated chondrocyte sample and
lane 3 the collagen II standard. The arrows on the right show the
migration of CNBr fragments prepared from bovine cartilage
collagen II standards generously provided by Drs Eyre and Wu.
Collagen II standards from chicken sternum digested with CNBr in
parallel to the migrated chondrocyte samples showed similar
electrophoretic mobility to those provided by Dr Eyre (data not
shown). The arrow heads on the left of the figure show the position
in the gel of CNBr peptides from a collagen I bovine dermis
standard.
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associated with cell migration, including formation of lamel-
lipodia at the leading edge and multiple filopodia around the
cell body. As expected, the motile cells were well spread on
the FN substratum, as opposed to the stationary cells,
which looked more rounded and compact. As noted pre-
viously, the rounded chondrocyte morphology has been
associated with stable chondrocyte expression, and thus it
may seem contradictory that the attached, motile popula-
tion of cells is well differentiated. However, it is important to
consider that: (1) dedifferentiation of chondrocytes in cul-
ture is a time-dependent process14,15 and (2) systematic
studies have convincingly shown that a direct correlation
between morphology and phenotypic expression cannot be
made14,31,32. Modulation of chondrocyte expression in
attached cultures can be viewed at least in part as a varied
spectrum of changes in the cytoskeletetal architecture of
the cell, governed by the endogenous chemistry of the cells
and their interaction with a number of environmental
factors. It is possible that chondrocyte spreading may
progress to matrix dedifferentiation under permissive con-
ditions. However, the finding that motile chondrocytes
express collagen type II, but not type I, indicates that the
changes leading to motogenesis and to dedifferentiation
are not the same.
Previous studies have shown that cells move best at an
intermediate attachment strength and that very tight
Fig. 6. Individual-cell videotracking: Example of a non-motile and motile cell. The cell images were captured at 0, 180, 360, 540 and 720 min
for a non-motile cell in the composite panel A and for a motile cell in panel B. At each time point, the shape of the cells is outlined. The cell
at time 0 shows the superimposed outlines of the cell during subsequent movement captured from the individual frames shown in the
different panels. The arrows show the direction of movement, and the inset on the lower right shows the cell trajectories.
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adhesion to the substratum impedes cell migration24,33,34.
This is intuitively sound, since cells must detach their rear
to move forward. For several cell types, a bimodal pattern
of migration is observed as the substratum concentration
increases. This is not the case for chondrocyte migration on
FN, and may be due to production by the chondrocyte of
anti-adhesive or ‘matricellular’ proteins in response to FN
and IGF-I stimulation35–37. In any event, the finding that FN
can support chondrocyte migration is of interest because of
the noted importance of this matrix protein in chondro-
cyte pathophysiology, particularly in view of its dramatic
increase during osteoarthritis38.
An important conclusion herein is that a population
of chondrocytes possesses the complex, basic cellular
machinery required for locomotion. However, some con-
sideration of the in vitro experimental conditions used for
this study and their limitations are noteworthy. Cell attach-
ment prior to videotracking was not maximal, possibly
due to the experimental conditions. FCS induced strong
proliferation of the young bovine chondrocytes, and for the
present study, it was important to maintain low cell density
and thereby prevent interactions and/or superimposition of
cells prior to or during migration. Instead of serum, we
added IGF-I prior to the initiation of, and during, videotrack-
ing. Previous work indicated that IGF can substitute for
serum in the induction of chondrocyte attachment to FN39,
and IGF was not as mitogenic as FCS. Selecting micro-
scopic fields enriched in well-attached cells for videotrack-
ing also circumvented the problem. The rest of the cells
(approximately two-third of the total; not tracked) appeared
to be loosely attached and retained a globular rather than
flattened shape (this estimate is based on cell counting in
36 microscopic fields in a representative experiment).
Amongst the videotracked cells, approximately one-third
was motile. A plausible hypothesis is that the motile cells
belong to a specialized population of cartilage cells, e.g.,
the superficial cartilage cells that produce proteins
associated with migration, such as the contractile protein α
smooth muscle actin17,18.
The speed of chondrocyte movement measured here
overlapped with the lower range of motion of other cells (as
examples, speeds on the order of 20, 80, 90 and 360–
720 µm/h have been measured for human smooth muscle
cells, mouse fibroblasts, human mammary epithelial cells
and neutrophils, respectively24,33,40,41). Thus, the findings
reported are in agreement with the existence of a small
subpopulation of relatively slow moving cells in cartilage.
While a direct extrapolation from our in vitro observations to
events in cartilage cannot be made, it is possible that the
migration of chondrocytes on 2D surfaces reflect—at least
in part—their physiological attributes. For example, the
slow speed of migration may contribute to the lack of
significant repair potential in vivo. Further, the finding that
chondrocyte motility is independent of dedifferentiation
provides an optimistic note that this cellular property
could be studied and modulated for future engineering of
cartilage repair.
Chondrocyte movement within cartilage matrix would
require additional cellular skills, and an important future aim
is to harvest and expand sufficient motile cells to examine
their migration on 3D environments. Complex 3D matrices
contribute to cell migration in positive and negative ways.
During cell migration, collagen fibers and fibrils may pro-
vide ‘tracks’ along which cells can move and/or the fibrillar
meshwork may provide points of secure attachment where
cells can insert their processes and impel themselves
forward42. On the other hand, some matrix components,
for example the proteoglycans decorin and versican, and
the FN related protein fibulin may provide inhibitory
signals43–45. Further, the matrix may present a physical
impediment; some cells may be able to squeeze or move
through matrix meshwork42, while others may require the
aid of proteolytic enzymes at the leading edge to move
through dense matrices46. It will be important to address
the ability of chondrocytes derived from normal and
osteoarthritic cartilage to locomote through cartilage, as the
increase in chondrocytic proteases that occurs during the
disease1 may aid cell motility in these environments. In this
regard, Kouri et al.47 studied knee cartilage from normal
and osteoarthritic human subjects by light and transmission
electron microscopy and pointed out that many chondro-
cytes within the tissue displayed elements of motile cells,
including numerous filopodia, a primary cilia and cyto-
skeletal rearrangements.
In summary, the experiments described in this article
provide novel definitive evidence that chondrocytes are
capable of migration. This is based on: (1) demonstration
of migration using two independent methods of analysis;
(2) direct examination of the phenotype of migrated cells;
(3) the demonstration that the morphological and kinetic
properties of the moving cells are consonant with those of
other motile cell types; and (4) direct visualization of motion
by videotracking microscopy. While future studies will be
challenging, these findings open the door to exciting
possibilities for understanding the mechanisms by which
chondrocytes move and for devising ways to enhance their
motogenic potential for tissue engineering applications.
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